EASD 2025 15 - 19 September 2025

Incidence of non-arteritic ischaemic optic neuropathy (NAION) across completed phase 2, 3 and 4 trials evaluating the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide

Authors :

Tina Vilsbøll^1,2; Dikshit A³; Lloyd Paul Aiello⁴; Cecilia Rönnbäck⁵; Michael Stellfeld⁵; Michael Larsen⁶;

Affiliations

View Details Hide Details

Keywords

Diabetes

Congress oral presentation

GLP-1 RA

Liraglutide

Semaglutide

PHASE 3 (RCT)

Are you a healthcare professional?